Total Payments
$10,056
2024 Payments
$1,132
Companies
53
Transactions
710
Medicare Patients
978
Medicare Billing
$159,048
Payment Breakdown by Category
Food & Beverage$9,950 (98.9%)
Education$105.93 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,950 | 703 | 98.9% |
| Education | $105.93 | 7 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,075 | 71 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,052 | 82 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $902.32 | 63 | $0 (2024) |
| PFIZER INC. | $843.51 | 102 | $0 (2023) |
| Astellas Pharma US Inc | $678.01 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $676.43 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $647.53 | 47 | $0 (2024) |
| Novo Nordisk Inc | $595.13 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $461.33 | 31 | $0 (2023) |
| ABBVIE INC. | $436.71 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,132 | 59 | Exact Sciences Corporation ($159.09) |
| 2023 | $1,026 | 53 | Lilly USA, LLC ($213.73) |
| 2022 | $1,256 | 79 | Lilly USA, LLC ($275.91) |
| 2021 | $1,607 | 106 | PFIZER INC. ($175.16) |
| 2020 | $1,192 | 81 | PFIZER INC. ($211.02) |
| 2019 | $1,274 | 106 | Janssen Pharmaceuticals, Inc ($149.99) |
| 2018 | $1,319 | 115 | Janssen Pharmaceuticals, Inc ($318.67) |
| 2017 | $1,249 | 111 | Janssen Pharmaceuticals, Inc ($261.31) |
All Payment Transactions
710 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: HFCWO | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Biological | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: HFCWO | ||||||
| 10/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.07 | General |
| 10/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: HFCWO | ||||||
| 09/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Biological | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Neuroscience | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: DIABETES | ||||||
| 08/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Biological | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 185 | 421 | $65,066 | $20,357 |
| 2022 | 4 | 187 | 455 | $85,448 | $31,775 |
| 2021 | 6 | 214 | 577 | $97,670 | $43,320 |
| 2020 | 11 | 392 | 963 | $155,921 | $63,595 |
Total Patients
978
Total Services
2,416
Medicare Billing
$159,048
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 221 | $38,621 | $11,369 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $9,651 | $3,941 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 41 | $11,048 | $3,559 | 32.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 21 | 88 | $5,022 | $1,087 | 21.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $477.00 | $348.60 | 73.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 18 | 19 | $247.00 | $52.05 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 279 | $46,055 | $17,117 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 139 | $33,593 | $11,585 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $5,500 | $2,821 | 51.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 15 | 15 | $300.00 | $252.74 | 84.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 362 | $69,628 | $30,328 | 43.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 79 | $11,462 | $4,873 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $6,700 | $3,281 | 49.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 22 | 53 | $5,300 | $2,876 | 54.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 13 | 36 | $4,140 | $1,560 | 37.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 22 | 22 | $440.00 | $403.04 | 91.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 521 | $106,610 | $38,408 | 36.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 61 | 138 | $13,800 | $8,364 | 60.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 40 | 40 | $10,000 | $4,612 | 46.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 28 | 72 | $8,280 | $3,312 | 40.0% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Office | 2020 | 27 | 32 | $3,840 | $2,221 | 57.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 40 | $5,406 | $2,075 | 38.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 17 | 29 | $3,480 | $1,830 | 52.6% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2020 | 28 | 28 | $3,080 | $1,650 | 53.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 41 | 41 | $820.00 | $732.76 | 89.4% |
About Dr. Bryant Bojewski, DO
Dr. Bryant Bojewski, DO is a Internal Medicine healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124009188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryant Bojewski, DO has received a total of $10,056 in payments from pharmaceutical and medical device companies, with $1,132 received in 2024. These payments were reported across 710 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($9,950).
As a Medicare-enrolled provider, Bojewski has provided services to 978 Medicare beneficiaries, totaling 2,416 services with total Medicare billing of $159,048. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Erie, PA
- Active Since 11/08/2005
- Last Updated 12/05/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124009188
Products in Payments
- XARELTO (Drug) $848.60
- JARDIANCE (Drug) $376.90
- EMGALITY (Drug) $372.96
- Cologuard Collection Kit (Device) $365.49
- TRELEGY ELLIPTA (Drug) $334.49
- Ozempic (Drug) $317.52
- TRULICITY (Drug) $314.20
- JANUVIA (Drug) $285.57
- CHANTIX (Drug) $262.91
- TRADJENTA (Drug) $232.40
- XIFAXAN (Drug) $231.63
- STIOLTO RESPIMAT (Drug) $228.31
- Myrbetriq (Drug) $225.28
- ENTRESTO (Drug) $220.67
- MYRBETRIQ (Drug) $206.95
- INVOKANA (Drug) $186.16
- Veozah (Drug) $180.78
- UBRELVY (Drug) $179.64
- VRAYLAR (Drug) $177.33
- ELIQUIS (Drug) $172.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Erie
Gerald Bishop, Md, MD
Internal Medicine — Payments: $398,351
Internal Medicine $398,351
Orestis Pappas, Md, MD
Internal Medicine — Payments: $241,617
Internal Medicine $241,617
Dr. James Ohr, D.o, D.O
Internal Medicine — Payments: $15,018
Internal Medicine $15,018
Dr. Madalina Opreanu, M.d, M.D
Internal Medicine — Payments: $8,181
Internal Medicine $8,181
Dr. Thomas Geisler, D.o, D.O
Internal Medicine — Payments: $7,482
Internal Medicine $7,482
Danielle Hansen, Do, DO
Internal Medicine — Payments: $5,901
Internal Medicine $5,901